Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.

Purpose: The safety and efficacy of the second U.S.-approved long-acting inhaled anticholinergic for controlling bronchospasm in patients with chronic obstructive pulmonary disease (COPD) are reviewed.